Reporting owner · CIK 0001733282

Qiming Managing Directors Fund VI, L.P.

SEC Form 4 history across 1 companies, 12 transactions and 1 filings.

10%Alamar Biosciences, Inc.
Open-market transaction mix0% buys0 buys · 12 sales
Latest filingOct 19, 2026, 08:30 PM

Available history · Oct 15, 2026 – Oct 16, 2026

Filings1Form 4 records
Buying$00 purchases
Selling$4.8M12 sales
Net value−$4.8MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Qiming Managing Directors Fund VI, L.P. transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$676View disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$567View disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$2.37kView disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$54View disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$2.54kView disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$870kView disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$2.14kView disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$727kView disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$9.18kView disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$3.11MView disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$254View disclosure →
ALMRAlamar Biosciences, Inc.
Qiming Managing Directors Fund VI, L.P.10%S · saleSEC filing ↗-$83.8kView disclosure →
Open a transaction for shares, transaction date, ownership and the original SEC filing.

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at Alamar Biosciences, Inc. on Oct 16, 2026 valued at $676.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Alamar Biosciences, Inc. on Oct 16, 2026 valued at $676.

Review SEC filing

Monthly open-market activity

Last 1 reported months · purchases and sales

View exact monthly values
MonthPurchasesSalesBuy valueSale valueNet value
Oct 2026012$0.00$4,816,120.73-$4,816,120.73

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$401.3K
Median P/S size$2.5K
Direct0
Indirect12
Oct 16, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern10Large Salesize3Repeat Sellerpattern10

Associated companies

Companies in the disclosed reporting history

Alamar Biosciences, Inc.ALMR · 12 transactions · latest Oct 19, 2026, 08:30 PM

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

12 observations · Oct 15, 2026 – Oct 16, 2026. Window ends at the latest available report, not today.

Selected observation · Oct 16, 20261,890,817 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Oct 15, 2026182,139Oct 19, 2026View transaction
Oct 15, 2026182,130Oct 19, 2026View transaction
Oct 15, 20266,769,018Oct 19, 2026View transaction
Oct 15, 20266,768,693Oct 19, 2026View transaction
Oct 15, 20261,579,421Oct 19, 2026View transaction
Oct 15, 20261,579,345Oct 19, 2026View transaction
Oct 15, 20261,890,932Oct 19, 2026View transaction
Oct 15, 20261,890,842Oct 19, 2026View transaction
Oct 16, 2026182,128Oct 19, 2026View transaction
Oct 16, 20266,768,605Oct 19, 2026View transaction
Oct 16, 20261,579,324Oct 19, 2026View transaction
Oct 16, 20261,890,817Oct 19, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Qiming Managing Directors Fund VI, L.P. Insider Activity FAQ

SEC Form 4 context

Who is Qiming Managing Directors Fund VI, L.P.?

Qiming Managing Directors Fund VI, L.P. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001733282.

Which companies has Qiming Managing Directors Fund VI, L.P. reported transactions for?

Alamar Biosciences, Inc.

When was Qiming Managing Directors Fund VI, L.P.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Qiming Managing Directors Fund VI, L.P.'s latest insider sale?

sale at Alamar Biosciences, Inc. on Oct 16, 2026 valued at $676.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.